Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

1.

Lipid mediators in diabetic nephropathy.

Srivastava SP, Shi S, Koya D, Kanasaki K.

Fibrogenesis Tissue Repair. 2014 Sep 3;7:12. doi: 10.1186/1755-1536-7-12. eCollection 2014. Review.

PMID:
25206927
[PubMed]
Free PMC Article
2.

The role of ubiquitination and sumoylation in diabetic nephropathy.

Gao C, Huang W, Kanasaki K, Xu Y.

Biomed Res Int. 2014;2014:160692. doi: 10.1155/2014/160692. Epub 2014 Jun 4.

PMID:
24991536
[PubMed - in process]
Free PMC Article
3.

Low-protein diet for diabetic nephropathy.

Otoda T, Kanasaki K, Koya D.

Curr Diab Rep. 2014 Sep;14(9):523. doi: 10.1007/s11892-014-0523-z.

PMID:
24986448
[PubMed - in process]
4.

The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.

Nagai T, Nitta K, Kanasaki M, Koya D, Kanasaki K.

Clin Exp Nephrol. 2014 Jul 1. [Epub ahead of print]

PMID:
24975544
[PubMed - as supplied by publisher]
5.

Clinical therapeutic strategies for early stage of diabetic kidney disease.

Kitada M, Kanasaki K, Koya D.

World J Diabetes. 2014 Jun 15;5(3):342-56. doi: 10.4239/wjd.v5.i3.342. Review.

PMID:
24936255
[PubMed]
Free PMC Article
6.

Cancer biology in diabetes.

Sen S, He Y, Koya D, Kanasaki K.

J Diabetes Investig. 2014 May 4;5(3):251-64. doi: 10.1111/jdi.12208. Epub 2014 Mar 5. Review.

PMID:
24843770
[PubMed]
Free PMC Article
7.

Three ileus cases associated with the use of dipeptidyl peptidase-4 inhibitors in diabetic patients.

Kanasaki K, Konishi K, Hayashi R, Shiroeda H, Nomura T, Nakagawa A, Nagai T, Takeda-Watanabe A, Ito H, Tsuda S, Kitada M, Fujii M, Kanasaki M, Nishizawa M, Nakano Y, Tomita Y, Ueda N, Kosaka T, Koya D.

J Diabetes Investig. 2013 Nov 27;4(6):673-5. doi: 10.1111/jdi.12095. Epub 2013 May 8.

PMID:
24843724
[PubMed]
Free PMC Article
8.

N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition.

Nagai T, Kanasaki M, Srivastava SP, Nakamura Y, Ishigaki Y, Kitada M, Shi S, Kanasaki K, Koya D.

Biomed Res Int. 2014;2014:696475. doi: 10.1155/2014/696475. Epub 2014 Mar 24.

PMID:
24783220
[PubMed - in process]
Free PMC Article
9.

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.

Kanasaki K, Nagai T, Nitta K, Kitada M, Koya D.

Front Pharmacol. 2014 Apr 14;5:70. doi: 10.3389/fphar.2014.00070. eCollection 2014. Review.

PMID:
24782774
[PubMed]
Free PMC Article
10.

Specific activation of K-RasG12D allele in the bladder urothelium results in lung alveolar and vascular defects.

Ayala de la Peña F, Kanasaki K, Kanasaki M, Vong S, Rovira C, Kalluri R.

PLoS One. 2014 Apr 23;9(4):e95888. doi: 10.1371/journal.pone.0095888. eCollection 2014.

PMID:
24760005
[PubMed - in process]
Free PMC Article
11.

Combat diabetic nephropathy: from pathogenesis to treatment.

Gohda T, Mima A, Moon JY, Kanasaki K.

J Diabetes Res. 2014;2014:207140. doi: 10.1155/2014/207140. Epub 2014 Mar 11. No abstract available.

PMID:
24741570
[PubMed - in process]
Free PMC Article
12.

Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.

Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D.

Diabetes. 2014 Jun;63(6):2120-31. doi: 10.2337/db13-1029. Epub 2014 Feb 26.

PMID:
24574044
[PubMed - indexed for MEDLINE]
13.

Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.

Koya D, Kitada M, Kume S, Kanasaki K.

Clin Exp Nephrol. 2014 Apr;18(2):210-3. doi: 10.1007/s10157-013-0908-3. Epub 2013 Nov 14.

PMID:
24221306
[PubMed - in process]
14.

Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.

Wada T, Miyashita Y, Sasaki M, Aruga Y, Nakamura Y, Ishii Y, Sasahara M, Kanasaki K, Kitada M, Koya D, Shimano H, Tsuneki H, Sasaoka T.

Am J Physiol Endocrinol Metab. 2013 Dec 1;305(11):E1415-25. doi: 10.1152/ajpendo.00419.2013. Epub 2013 Oct 15.

PMID:
24129399
[PubMed - indexed for MEDLINE]
15.

MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT.

Srivastava SP, Koya D, Kanasaki K.

Biomed Res Int. 2013;2013:125469. doi: 10.1155/2013/125469. Epub 2013 Sep 8. Review.

PMID:
24089659
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R.

Nat Med. 2013 Jul;19(7):810-1. doi: 10.1038/nm.3081. No abstract available.

PMID:
23836214
[PubMed - indexed for MEDLINE]
17.

Calorie restriction in overweight males ameliorates obesity-related metabolic alterations and cellular adaptations through anti-aging effects, possibly including AMPK and SIRT1 activation.

Kitada M, Kume S, Takeda-Watanabe A, Tsuda S, Kanasaki K, Koya D.

Biochim Biophys Acta. 2013 Oct;1830(10):4820-7. doi: 10.1016/j.bbagen.2013.06.014. Epub 2013 Jun 23.

PMID:
23800577
[PubMed - indexed for MEDLINE]
18.

Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction.

Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, Ni W, Kalluri R, Werb Z.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11109-14. doi: 10.1073/pnas.1309561110. Epub 2013 Jun 17.

PMID:
23776237
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The biological consequence of obesity on the kidney.

Kanasaki K, Kitada M, Kanasaki M, Koya D.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv1-7. doi: 10.1093/ndt/gft098. Epub 2013 Jun 5.

PMID:
23743020
[PubMed - in process]
20.

Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules.

Xu L, Kanasaki M, He J, Kitada M, Nagao K, Jinzu H, Noguchi Y, Maegawa H, Kanasaki K, Koya D.

Biochim Biophys Acta. 2013 Oct;1832(10):1605-12. doi: 10.1016/j.bbadis.2013.05.003. Epub 2013 May 11.

PMID:
23669346
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk